🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

23 recruiting trials

for Nasopharyngeal Cancinoma (NPC)

EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma NCT06802835Phase 1, Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: EGFR Antibody, PD-1 antibody, Gemcitabine, Cisplatin, IMRT Prospective Immuno-Radiomic Profiling in Nasopharyngeal Carcinoma Treated With Proton or Photon Chemoradiotherapy NCT07232680n/a1 site📍 Taoyuan City Cheng-En Hsieh · Tests: Proton chemoradiotherapy, Photon chemoradiotherapy LDRT and Chemoimmunotherapy in NPC With Liver Metastasis NCT06788002Phase 28 sites📍 Changsha📍 Changsha📍 Changsha Hunan Cancer Hospital · Tests: Low-dose radiotherapy combine with chemoimmunotherapy Becotatug Vedotin for LA-NPC With a Suboptimal Response to Induction Chemotherapy Combined With Immunotherapy NCT07496190Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Becotatug vedotin, Becotatug vedotin Intratumoral Injection of Recombinant Human Endostatin Adenovirus (EDS01) for the Treatment of Recurrent or Metastatic Head and Neck Tumors NCT07625423Phase 11 site📍 Chengdu West China Hospital · Tests: EDS01 1.0×10^11 VP + Toripalimab, EDS01 5.0×10^11 VP + Toripalimab, EDS01 1.0×10^12 VP + Toripalimab Development and Validation of a Deep Learning Model to Predict Distant Metastases in Nasopharyngeal Carcinoma Using Whole Slide Imaging and MRI NCT06831357n/a2 sites📍 Guangzhou📍 Guangzhou Sun Yat-sen University Tislelizumab Combined With Capecitabine for Nasopharyngeal Carcinoma With Residual EBV DNA After Radiotherapy NCT07067268Phase 21 site📍 Shanghai Fudan University · Tests: Adjuvant therapy Prophylactic Nanocrystalline Megestrol Acetate Versus Placebo for Chemoradiotherapy-Related Anorexia in Nasopharyngeal Carcinoma NCT07796789Phase 33 sites📍 Guangzhou📍 Changsha📍 Fuzhou Sun Yat-sen University · Tests: Nanocrystalline Megestrol Acetate Oral Suspension, Placebo SBRT Combined With Nimotuzumab and Tislelizumab for Oligoprogressive Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of Immunotherapy NCT06676722Phase 22 sites📍 Xiamen📍 Xiamen The First Affiliated Hospital of Xiamen University · Tests: SBRT combined with Nimotuzumab followed by Tislelizumab International Collaborative Study on AJCC/UICC TNM-10 for Nasopharyngeal Cancer NCT07013461n/a1 site📍 Shenzhen The University of Hong Kong-Shenzhen Hospital Phase 3 Trial Comparing IMRT or IMPT Plus CIRT for Patients With NPC NCT06846450Phase 31 site📍 Shanghai Lin Kong, MD · Tests: Intensity-modulated proton radiation therapy, Intensity-modulated photon radiation therapy, Intensity-modulated carbon … IMRT Alone for Stage IB Nasopharyngeal Carcinoma Without High-Risk Features NCT07376603n/a1 site📍 Fuzhou Qiaojuan Guo · Tests: IMRT along QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma. NCT06749899Phase 319 sites📍 Fuzhou📍 Dongguan📍 Foshan Sun Yat-Sen University Cancer Center · Tests: QL1706, Gemcitabine, Cisplatin, Intensity-modulated radiotherapy Prevention and Treatment of Radiation-Induced Oral Mucositis in NPC With Houyanqing Oral Liquid NCT07311772Phase 316 sites📍 Beijing📍 Fuzhou📍 Guangzhou Sun Yat-sen University · Tests: Houyanqing Oral Liquid, Conventional Treatment for Radiation-Induced Oral Mucositis Adaptive Immunotherapy for Nasopharyngeal Carcinoma NCT07154069Phase 31 site📍 Guangzhou Sun Yat-sen University · Tests: Radical radiotherapy of nasopharynx and neck, Capecitabine, Concurrent chemoradiotherapy (cCRT), Toripalimab Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal Carcinoma NCT07362979Phase 24 sites📍 Dongguan📍 Guangzhou📍 Shenzhen Sun Yat-sen University · Tests: GP plus Toripalimab Induction chemotherapy+CCRT, TP plus Toripalimab Induction chemotherapy+CCRT, TPC plus Toripalimab … LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC NCT07325539Phase 22 sites📍 Guangzhou📍 Shenzhen Sun Yat-sen University · Tests: Gemcitabine(GEM), Cisplatin, Toripalimab, LDRT Nab-TPC vs GP Combined With Camrelizumab in the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma NCT06669611Phase 31 site📍 Guangzhou Sun Yat-sen University · Tests: Camrelizumab combined GP chemotherapy, Camrelizumab combined TPC chemotherapy A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers NCT05910827Phase 1, Phase 220 sites📍 Sydney📍 Westmead📍 Brisbane Hummingbird Bioscience · Tests: HMBD-001, Docetaxel, Cetuximab Reduced Dose Radiotherapy vs Standard Dose Radiotherapy for Early Stage Nasopharyngeal Carcinoma NCT06912698Phase 31 site📍 Guangzhou Hai-Qiang Mai,MD,PhD · Tests: Reduced dose radiation, Standard dose radiation Maintenance Immunotherapy With Deferred Salvage Radiotherapy After Response to Chemoimmunotherapy in Recurrent Nasopharyngeal Carcinoma NCT07528183Phase 24 sites📍 Fuzhou📍 Guangzhou📍 Nanning Sun Yat-sen University · Tests: Maintenance Immunotherapy With Deferred Salvage Radiotherapy A Deep Learning Model for Diagnosing Lymph Node Metastasis in Nasopharyngeal Carcinoma(NPC) NCT06829147n/a1 site📍 Guangzhou Sun Yat-sen University Efficacy and Safety of Becotatug Vedotin (MRG003) Combined With Anti-PD1 as Maintenance Therapy for Recurrent and Metastatic Nasopharyngeal Carcinoma NCT07705243Phase 31 site📍 Guangzhou Sun Yat-sen University · Tests: Anti-PD1, Anti-PD1 combined with Becotatug Vedotin
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy